RGC vs. MSTY
RGC (Regencell Bioscience Holdings Limited) is a stock, while MSTY (YieldMax™ MSTR Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax. Over the past year, RGC returned -53.25% vs -66.58% for MSTY. At a correlation of -0.02, they often move in opposite directions.
Performance
RGC vs. MSTY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RGC achieves a -47.24% return, which is significantly lower than MSTY's -27.80% return.
RGC
- 1D
- 5.42%
- 1M
- -57.05%
- YTD
- -47.24%
- 6M
- -56.12%
- 1Y
- -53.25%
- 3Y*
- -22.17%
- 5Y*
- —
- 10Y*
- —
MSTY
- 1D
- -4.55%
- 1M
- -31.74%
- YTD
- -27.80%
- 6M
- -29.80%
- 1Y
- -66.58%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
RGC vs. MSTY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
RGC Regencell Bioscience Holdings Limited | -47.24% | 325.10% | -36.59% |
MSTY YieldMax™ MSTR Option Income Strategy ETF | -27.80% | -42.71% | 212.16% |
Correlation
The correlation between RGC and MSTY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Feb 22, 2024 | -0.02 |
The correlation between RGC and MSTY shifts across timeframes, from -0.02 (all time) to 0.08 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RGC vs. MSTY — Risk / Return Rank
RGC
MSTY
RGC vs. MSTY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and YieldMax™ MSTR Option Income Strategy ETF (MSTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RGC | MSTY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.79 | ||
| Sortino ratioReturn per unit of downside risk | +2.65 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 0.79 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | -0.93 | +0.26 |
| Martin ratioReturn relative to average drawdown | -1.26 | -1.35 | +0.09 |
Loading charts...
Drawdowns
RGC vs. MSTY - Drawdown Comparison
The maximum RGC drawdown since its inception was -98.82%, which is greater than MSTY's maximum drawdown of -71.79%. Use the drawdown chart below to compare losses from any high point for RGC and MSTY.
Loading charts...
Drawdown Indicators
| RGC | MSTY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.82% | -71.79% | -27.03% |
Max Drawdown (1Y)Largest decline over 1 year | -80.12% | -71.79% | -8.33% |
Max Drawdown (3Y)Largest decline over 3 years | -98.82% | — | — |
Current DrawdownCurrent decline from peak | -98.74% | -71.62% | -27.12% |
Average DrawdownAverage peak-to-trough decline | -64.85% | -26.97% | -37.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 43.23% | 49.36% | -6.13% |
Volatility
RGC vs. MSTY - Volatility Comparison
Regencell Bioscience Holdings Limited (RGC) has a higher volatility of 30.22% compared to YieldMax™ MSTR Option Income Strategy ETF (MSTY) at 19.32%. This indicates that RGC's price experiences larger fluctuations and is considered to be riskier than MSTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RGC | MSTY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.22% | 19.32% | +10.90% |
Volatility (6M)Calculated over the trailing 6-month period | 112.48% | 49.66% | +62.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 191.03% | 62.02% | +129.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 283.09% | 71.82% | +211.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 283.09% | 71.82% | +211.27% |
Dividends
RGC vs. MSTY - Dividend Comparison
RGC has not paid dividends to shareholders, while MSTY's dividend yield for the trailing twelve months is around 286.06%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
MSTY YieldMax™ MSTR Option Income Strategy ETF | 286.06% | 294.61% | 104.56% |
RGC Regencell Bioscience Holdings Limited | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RGC and MSTY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RGC has higher volatility (30.22%) compared to MSTY (19.32%). In terms of maximum drawdown, RGC dropped -98.82% vs MSTY's -71.79%.
RGC currently has the higher Sharpe Ratio (-0.29 vs -1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RGC and MSTY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer